Clinical pharmacokinetics of 123I-Iaza in healthy volunteers

Nuclear Medicine Communications

Volumn 20, Issue 6, 1999, Pages 559-567

  Stypinski, D ^a,c   Wiebe, L I ^a   McEwan, A J ^a,b   Schmidt, R P ^b   Tam, Y K ^a   Mercer, J R ^a,c  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MDS Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 NITROIMIDAZOLE DERIVATIVE; IODOAZOMYCIN ARABINOSIDE I 123; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; IODOAZOMYCIN ARABINOSIDE; NITROIMIDAZOLE DERIVATIVE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; RADIOACTIVITY; STEADY STATE; ANOXIA; BIOLOGICAL MODEL; HALF LIFE TIME; MIDDLE AGED; SCINTISCANNING; TISSUE DISTRIBUTION;

ADULT; ANOXIA; FEMALE; HALF-LIFE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NITROIMIDAZOLES; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 0032587277     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199906000-00011     Document Type: Article

References (18)

1. Mercer JR, Mannan RH, Somayaji VV et al. Sugar-coupled 2-nitroimidazoles: Novel in vivo markers of hypoxic tumor tissue. In: Maddelena DJ, Snowdon GM, Boniface GR, eds. Advances in radiopharmacology, Proceedings of the 6th International Symposium on Radiopharmacology. Wollongong: University of Wollongong Writing Services, 1990: 104-113.
2. 123I-iodoazomycin arabinoside: Preliminary report of a clinical study. Br J Cancer 1992; 65: 90-95
3. Urtasun RC, Parliament MB, McEwan AJ et al. Measurement of hypoxia in human tumours by non-invasive SPECT imaging of iodoazomycin arabinoside. Br J Cancer 1996; 74(suppl. 27): S209-S212.
4. Groshar D, McEwan AJB, Parliament MB et al. Imaging tumor hypoxia and tumor perfusion. J Nucl Med 1993; 34: 885-888.
5. Al-Arafaj A, Ryan EA, Hutchison K et al. An evaluation of iodine-123 iodoazomycin arabinoside as a marker of localized tissue hypoxia in patients with diabetes mellitus. Eur J Nucl Med 1994; 21: 1338-1342.
6. 123I-iodoazomy-cin arabinoside-a possible marker of hypoxia in rheumatoid arthritis. CANM Annual Scientific Meeting, Quebec City, PQ, 1996.
7. Lythgoe MF, Williams SR, Wiebe LI et al. Autoradiographic imaging of cerebral ischemia using a combination of blood flow and hypoxic markers in an animal model. Eur J Nucl Med 1997; 24: 16-20.
8. Vinjamuri SM, van den Broek P, Maltby P et al. Identification of hypoxic regions in traumatic brain injury (TBI). European Congress of Nuclear Medicine, Glasgow, August 1997.
9. Mannan, RH, Somayaji W, Lee J et al. Radioiodinated 1-(5-iodo-5-deoxy-ß-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA), a novel marker of tissue hypoxia. J Nucl Med 1991; 32: 1764-1770.
10. Mannan, RH. Novel non-invasive markers of tumor hypoxia. PhD thesis, University of Alberta, Edmonton, Alberta, 1991.
11. 123/125I]iodo-5-deoxyarabinofuranosyl)-2-nitroimidaz-ole, a marker of tissue hypoxia. J Pharm Biomed Anal 1997; 16: 1067-1073.
12. Gibaldi M, Perrier D. Pharmacokinetics, 2nd edn. New York: Marcel Dekker, 1982.
13. Ash DV, Smith MR, Bugden RD. Distribution of misonida-zole in human tumors and normal tissues. Br J Cancer 1979; 39: 503-509.
14. Williams LE, Odom-Maryon TL, Liu A et al. On the correction for radioactive decay in pharmacokinetic modeling. Med Phys 1995; 22: 1619-1626.
15. Wiebe LI. Radionuclides, radiotracers and radiopharmaceuticals for in vivo diagnosis. Radiat Physics Chem 1984; 24: 365-372.
16. Rasey JS, Grunbaum Z, Magee S et al. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiat Res 1987; 111: 292-304.
17. Koh W-J, Bergman KS, Rasey JS et al. Evaluation of oxygenation status during fractionated radiotherapy in nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys 1995; 33: 391-398.
18. 3H]fluoromisonidazole. Radiat Res 1995; 141: 28-36.